Advertisement
Advertisement
TMDX
TransMedics Group, Inc. Common Stock
114.00
USDSponsored
+4.66
+4.27%
Apr 10, 15:59 UTC -4
Closed
Pre-Market
112.12
-1.88
-1.65%
TMDX Earnings Reports
Positive Surprise Ratio
TMDX beat 18 of 28 last estimates.
64%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$176.13M
/$0.62
Implied change from Q4 25 (Revenue/ EPS)
+9.56%
/+16.98%
Implied change from Q1 25 (Revenue/ EPS)
+22.71%
/-11.43%
TransMedics Group, Inc. Common Stock earnings per share and revenue
On Feb 24, 2026, TMDX reported earnings of 0.53 USD per share (EPS) for Q4 25, beating the estimate of 0.39 USD, resulting in a 32.93% surprise. Revenue reached 160.76 million, compared to an expected 158.83 million, with a 1.21% difference. The market reacted with a -4.30% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of 0.62 USD, with revenue projected to reach 176.13 million USD, implying an increase of 16.98% EPS, and increase of 9.56% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were TransMedics Group, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, TransMedics Group, Inc. Common Stock reported EPS of $0.53, beating estimates by 32.93%, and revenue of $160.76M, 1.21% above expectations.
How did the market react to TransMedics Group, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -4.3%, changed from $137.78 before the earnings release to $131.85 the day after.
When is TransMedics Group, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for TransMedics Group, Inc. Common Stock's next earnings report?
Based on 12
analysts, TransMedics Group, Inc. Common Stock is expected to report EPS of $0.62 and revenue of $176.13M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement